Twin pregnancies are relatively common, but few populationbased data from developing countries exist regarding the rates and epidemiology of twinning, nor of the prognosis for survival of twins in an environment where obstetric and health care services are minimal. The most comprehensive populationbased data on twinning come from the Matlab Demographic Surveillance System. 1,2 Twinning rates varied by maternal age, parity and season, and the introduction of family planning increased the rate of twinning. Both neonatal and infant mortality rates were several times higher among twins than singletons, and gender differences in infant but not neonatal mortality were evident among twins of unlike gender.
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Methods
The population described in this study were participants in a randomized community trial conducted in Sarlahi district, Nepal. 3, 4 All married women of childbearing age living in 270 wards in the district were eligible to participate in the trial. Wards were randomly assigned to one of three treatment groups: placebo, vitamin A or beta-carotene. All eligible women within those wards received a capsule containing the assigned treatment each week. Local village-based women were trained to ask about menses in the past week, ascertain pregnancy status by history, provide the assigned capsule, and record compliance. Women who declared themselves pregnant were enrolled in a more detailed protocol that included a questionnaire completed around 4 months of pregnancy, that recorded their age, pregnancy history, date of last menstrual period, morbidity, physical work and diet in the past week. Another questionnaire ascertaining similar information was also completed around 7 months gestation. Each pregnancy was followed until an outcome of miscarriage or stillbirth, live birth, or maternal death occurred. For liveborn infants, vital status was ascertained at 3 months and 6 months of age. A verbal autopsy was done to obtain information on date and cause of death. All pregnancies that were reported on or after July 1994 and whose outcome occurred prior to March 1997 were included in this analysis. This allowed for 6 months of follow-up of all liveborn infants prior to the termination of the study.
For pregnancies that did not result in at least one live birth, there was no information about the multiplicity of the pregnancy, or of the gender of stillborn infants. For pregnancies that resulted in at least one live birth, the number of live and stillborn infants in each pregnancy was ascertained by interview with the mother at 3 months postpartum, but only the gender of liveborn children was recorded. Since the zygosity of twins was unknown in this study, the method described by Weinberg 5 and verified by Potter, 6 was used to estimate rates of mono-and dizygotic twinning among liveborn twins. This method doubles the observed number of pairs of twins of unlike gender and uses this number to estimate the rate of dizygotic twins, and the remaining number of pairs out of the total are classified as monozygotic. Gestational age was calculated using the date of last menstrual period or the menstrual data recorded weekly. If neither of these was available, the gestational age as determined by history on the second or third trimester questionnaire was used.
The rates of multiple births were estimated by taking the number of multiple births divided by the number of pregnancies, and expressed per 1000 pregnancies. The twinning rate was calculated as the number of pregnancies in which there were two fetuses, regardless of whether one was stillborn, divided by the number of pregnancies ascertained in the study. 'Perinatal' deaths were defined as those occurring within 7 days of birth among liveborn infants, and neonatal deaths as those within 28 days of birth. The cumulative 24-week mortality rate was calculated by taking all deaths of liveborn infants occurring within 24 weeks of birth, divided by the number of live births, and expressed as deaths per 1000 live births.
Logistic regression was used to identify risk factors associated with twinning, and to estimate the impact of treatment on twinning rates adjusted by various factors that might be associated with twinning risk. Relative risks were used to compare mortality rates of singletons with those of twins where both were live born. Pairwise odds ratios (OR) were used to assess the association of mortality within liveborn twin pairs. 7, 8 This OR is obtained by taking all possible pairs of liveborn twins and constructing a 2 × 2 table with numbers of pairs that are concordant for mortality (or survival) in diagonal boxes and the number of discordant pairs divided evenly between the other two boxes. The OR calculated from this table is the pairwise OR.
Results
There were a total of 15 868 pregnancies that ended in a live birth of at least one child during the follow-up period. The multiplicity of pregnancies with at least one liveborn infant was available for 15 726 (99.1%) pregnancies of 15 845 liveborn infants (Table 1 ). There were 116 pregnancies that resulted in two liveborn infants, and 137 pregnancies where 1 infant was live born, and 1 was stillborn. There were three sets of triplets, one with a liveborn infant and two stillbirths, and two where two infants were born alive, and one was stillborn. There was also one quadruplet, of which two infants were born alive and two were stillborn. This resulted in a twinning rate of 16.1 per 1000 pregnancies if both live and stillborn infants were counted (7.4 per 1000 if only liveborn twins were counted). This translates to a rate of 1 twin in 62 pregnancies (or 1 in 135 for liveborn twins only). The triplet and quadruplet rates were 0.32 and 0.06 per 1000 pregnancies, respectively (1 in 3125 and 1 in 16 667).
Gender was available for all sets of liveborn twins, but not for the stillborn infants. Among the 116 pairs of liveborn twins, 32 pairs were of opposite gender, and 84 were of the same gender. This resulted in a dizygotic twinning rate of 4.1 per 1000 pregnancies, and a rate of 3.3 per 1000 of monozygotic twins.
There were no significant differences in twinning rates (live and stillborn combined) by maternal age, but pregnancies of parity two or higher were 1.59 times (95% CI : 1.18, 2.14) more likely to produce twins ( Table 2 ). The twinning rate was higher among women who received vitamin A (adjusted OR = 1.30, 95% CI : 0.99, 1.71) and beta-carotene (adjusted OR = 1.44, 95% CI : 1.09, 1.89) than women who received placebo during the trial. The findings regarding maternal age, parity, gestational age and treatment effects were similar for twinning rates that included only liveborn twins. Gestational age was strongly associated with twinning, with twins having a shorter gestational age, even after adjusting for maternal age, parity and treatment effect. Other risk factors found not to be associated with twinning after adjustment for maternal age, parity, treatment group and gestational age were maternal smoking during pregnancy (OR = 0.98, P-value = 0.89), maternal mid upper arm circumference (OR = 0.984, P-value = 0.08), and seasonality (OR = 1.20, P-value = 0.24 for pre-monsoon versus monsoon, and OR = 1.05, P-value = 0.71 for pre-monsoon versus post-monsoon). There was also no interaction between maternal age and parity where both were continuous variables in the regression model (OR = 1.00, P-value = 0.83). Vital status through 24 weeks of age was available for 14 683 (92.7%) of these infants. The mortality within 7 days of birth for singletons and liveborn twins was 28.6 and 244.3 per 1000 live births (Table 3 ). This represents an 8.54-fold higher risk of death for twin infants compared with singletons. The 7-day mortality rate for twins where one was live born and the other stillborn was 68.2 per 1000 live births, or 2.38 times higher than for singletons, and 72% lower than for twins where both were live born. The neonatal mortality rate (deaths within 28 days of birth) was 44.5 and 325.8 per 1000 live births for singletons and liveborn twins, respectively, representing a 7.32-fold higher risk for twins. The mortality rate for twins where one was live born and the other stillborn was 90.9 per 1000 live births (a 2.04-fold higher risk than for singletons). The cumulative 24-week mortality was 65.8 per 1000 live births for singletons, and 5.84 times higher for liveborn twins. The highest risk period for mortality among liveborn twins, relative to singletons, was within the first 7 days, declining from an 8-fold excess risk in the first 7 days, to a 6.5-fold excess risk between 7 and 28 days, and a 3.9-fold excess risk from 28 days to 24 weeks. However, the excess risk for twins where only one was live born was relatively constant throughout the first 6 months of life, at around 2.4.
Among liveborn twins, the likelihood of both infants dying was high. The pairwise OR was 85.8 for 0-7-day deaths, 85.6 for neonatal deaths, and 52.0 for deaths 24 weeks of age and under. This means that if one selects one infant at random from a pair, and that infant dies within the first week of life, the other infant in the pair has an 86-fold higher risk of also dying within the first week of life. The declining pairwise OR reflect a reduced concordance in the risk of dying as twins survive into older ages. This reduced concordance is unrelated to the lower mortality rates observed among older twins. 7, 8 For singletons and liveborn twins, 0-7-day, neonatal, and 24-week cumulative mortality was slightly higher for males than for females (Table 4) . However, the gender difference was larger for twins than for singletons, especially during the period between 7 and 28 days. For singletons, the relative risks of death for males versus females was 1.14, 1.15 and 1.04 during the 0-7-day, neonatal, and 24-week period, respectively. For twins, the relative risks were 1.17, 1.41, and 1.14 for each of these periods. None of these were statistically different from one.
Discussion
Twinning rates appear to vary substantially across geographical areas and by ethnicity. [9] [10] [11] [12] [13] [14] [15] Some of this variation is due to differences in the definition of twinning, and whether stillborn infants are included or not. An additional problem is the higher rate of twinning in hospital-based studies than would be observed in the population, since twins would be more likely to deliver in hospitals. Rates of 10.6 and 14.9 per 1000 pregnancies were reported for whites and blacks, respectively, in California between 1922 and 1958. 9 The rate in the state of Georgia was 9.5 per 1000 pregnancies between 1974 and 1978. 11 These rates were population-based and included stillbirths. A large hospitalbased study in California found a rate of 8.9 per 1000 deliveries in a predominantly Mexican-American population. 12 Among Fijians of Indian ethnicity, the twinning rate was 6.2 per 1000 pregnancies, 13 but the rate was 9.0 per 1000 in a rural area outside of Bombay 15 and in Bangladesh. 1 The twinning rate, inclusive of stillbirths in our population-based study in Nepal was 12.6 per 1000 pregnancies in the placebo group (95% CI : 9.55, 15.65). This is somewhat higher than reported by other studies, but it is difficult to compare our rate with these other rates because the confidence intervals for many of the other studies were not given. However, if only the liveborn twins are used, the rate is 7.4 per 1000 pregnancies. The higher rate of twinning may be due to overreporting of stillbirths that accompany live births in this population, or there may have been underreporting of stillbirths in other populations. Alternately, the specific probing for stillbirths in this population may have led to higher rates of twinning than in other studies that relied on self-report without additional probing. Other population differences may be related to maternal age, parity and contraceptive use. Oral contraceptive use has been thought to increase the rate of twinning. 16 This was seen in Bangladesh where the rates of twinning were higher in a family planning intervention area than in a control area. 1 The use of oral contraceptives is likely lower than in Bangladesh, and maternal age and parity are likely similar. Hence, these factors are unlikely to explain the differences in the twinning rates.
While the rates of twinning may have been higher in Nepal than in Bangladesh, the ratio of dizygotic to monozygotic twins was comparable in the two populations (the ratio in Nepal was based only on liveborn twins, since gender was not available for twins where one was stillborn). Since the same method was used to estimate the rate of twinning by zygosity, this similarity reflects a comparable ratio of like to unlike gender pairs. The monozygotic twinning rate in Nepal was 3.3 per 1000, which is comparable to the relatively constant rates found worldwide to vary between 3 and 4 per 1000. 10, 17 The rate was 2.8, 4.7, and 3.6 per 1000 among Indians in Fiji, in rural India, and in Bangladesh, respectively. 1, 13, 15 Rates for whites, blacks, Chinese and Japanese in California varied from 3.9 to 4.8 per 1000. 9, 12 As was seen in Bangladesh, rural India, and Indians in Fiji, the rates of twinning in Nepal increased with increasing parity. In Bangladesh, the rate of twinning was highest among women 35 years and older, but the only difference in twinning by maternal age observed in Nepal was between women under versus over 20 years, and this difference disappeared when the twinning rate was adjusted for parity. The pattern of twinning by maternal age seen in Nepal is more similar to that seen among twins in California, where the rate increased until about age 37, after which it declined. 9 The variation in twinning rates by maternal age and parity is largely due to variations in dizygotic twinning, and is thought to be associated with gonadotrophin production. 9, 17 Social factors such as smoking, maternal nutritional status, seasonality and oral contraceptive use may also be associated with dizygotic rather than monozygotic twinning rates, but we were unable to examine this issue. However, smoking during pregnancy, maternal mid upper arm circumference in the second trimester, and seasonality were not associated with overall twinning rates in this study. Oral contraceptive use was not assessed but is known to be very low in this population.
There was more than an 8-fold difference in the neonatal mortality between twins and singletons in Nepal. The neonatal mortality rate was five times higher for twins than singletons in Bangladesh. 2 This increased neonatal mortality has also been seen in the US (4 times higher in California, 12 6.6 times higher in Georgia). 11 Since birthweight was not available for all liveborn infants, we were unable to see if this difference was entirely explained by birthweight, as has been seen in developed countries. 11, 18 Gestational age was available for a large proportion of pregnancies. After adjusting for gestational age, twins still had a higher mortality rate, except around full term (40-42 weeks), where mortality rates were comparable for liveborn twins and singletons. In Nepal female infants had slightly lower mortality rates in the peri and neonatal periods than male infants. This gender difference in survival was also seen among twins, and was larger than that seen among singletons. In Bangladesh, the mortality rates in the neonatal period were comparable among males and females, but this study only looked at twin pairs that were discordant for gender as a way to adjust for gestational age. 2 In our data, only 32 pairs of twins were discordant for gender, making a comparable analysis difficult. However, adjustment for gestational age among all infants, and among twins alone, reduced the gender difference in mortality, making our findings comparable to those in Bangladesh and Georgia among the twin pairs that were discordant for gender. 2, 19 The very high pairwise OR seen among twins is an indicator of the likelihood of survival of both infants as compared with survival of at least one infant. This suggests that the probability of a mother having no surviving offspring of a twin pregnancy where both are born alive is much higher than if the pregnancy was a singleton. This likelihood diminishes as the infants get beyond the first month of life, but is not entirely gone by 6 months of age.
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The impact of vitamin A or beta-carotene supplementation on the twinning rate has not been reported in any populations previously. Since supplementation started prior to conception in all these women, it is possible that vitamin A or beta-carotene may have acted to increase the rate of twinning. However, since we could not obtain information on pregnancies that were twins but did not result in a live birth, it is unclear whether the supplements increased the twinning rate, or improved survival in utero of twin infants. The increased twinning was seen for twins where both were live born, and for twins where only one was live born. This suggests that twinning rates may have been increased, rather than there being increased survival in utero. An analysis of five data sets in which multivitamin supplements were used found that four of the five studies showed a 30% to 60% greater prevalence of supplement use during the periconceptional period among those with multiple births and there was no association among pregnancies where supplementation started after embryogenesis was complete. 20 Although specific vitamins cannot be identified from these studies, the results do lend support to the notion of micronutrient supplementation's association with twinning rather than improved survival of multiple fetuses. The fact that there was no impact of supplementation on fetal survival, survival of singleton live births, or neonatal survival among twins in our study further supports this. 4 There was no difference in the fertility rates of singletons by supplement group. Hence, the impact of beta-carotene and vitamin A supplementation on fertility appears to be specific to twinning. If the impact of supplementation was to increase the twinning rate, rather than the survival of twins in utero, then the generalizability of these results to nutrition supplementation programmes in developing countries is likely limited when these are aimed at antenatal rather than pre or periconceptual supplementation. The increased perinatal mortality associated with twinning should not reduce the imperative for antenatal supplementation, and, since twinning rates are relatively low, should not reduce the imperative for pre or periconceptual supplements that can be demonstrated to have an impact on early infant mortality of singletons who constitute the vast majority of births.
In summary, the twinning rate was somewhat higher in this population than that reported in other developed and developing countries. Mortality was much higher among twins, as seen in other settings. A significantly higher twinning rate, or survival of twins in utero, was seen among women who had received vitamin A or beta-carotene supplements prior to conception and throughout pregnancy, although there was no impact of supplementation on survival of liveborn infants from twin pregnancies. Other planned trials of antenatal vitamin A supplementation may help answer the question of whether survival of twins in utero is increased by supplementation.
Few factors have been identified as causes of multiple births. 1 Ovulation-inducing drugs are known to substantially increase the rate, but this is likely to explain only a minority of all occurrences. A number of other conditions have been found to be associated with multiple birth, including seasonality at birth, maternal age, social class, and diet. 1 However, the evidence relies nearly exclusively on observational studies, since very few randomized interventions have been undertaken in the periconceptional period which are large enough to enable the study of a rare outcome such as multiple birth.
Until recently there was only evidence available from one such trial with a dietary intervention which was conducted in Hungary and published in 1992. 2 More than 4000 women were randomized to receive either a supplement containing different vitamins, minerals and trace elements or a supplement containing the trace elements only plus minute amounts of vitamin C, from at least one month prior to conception until the second missed menstrual period or later. The authors found a reduced occurrence of neural tube defects in the vitamin/mineral group (0 versus 6 cases), a finding which has contributed to current policies for preventing neural tube defects. A few years later, and more relevant to this commentary, the authors published results showing a significantly higher rate of twins in the group receiving vitamins and minerals, 3.8% versus 2.7%, which was an unexpected finding. 3, 4 The statistical power to differentiate between effects on dizygotic and monozygotic twin rates was limited, but both twin types tended to be increased in the intervention group. These results prompted an analysis based on five observational data sets collected in the US, where periconceptional use of dietary supplements had been assessed retrospectively after birth. In this exploratory analysis, published in 1997, 5 four of the five studies exhibited a positive association between the twin rate and use of multivitamins from 1 month before to 3 months after conception. When exposure was defined as only comprising post-conceptional supplement use, the associations got weaker or disappeared, a pattern which was interpreted to reflect an effect on twinning rather than an effect on viability of twin pregnancies.
Katz's et al.'s report 6 in this issue of the journal is based on a mega-trial conducted in a poor rural area of Nepal. The main finding of this randomized trial was a lower incidence of maternal deaths within 12 weeks of delivery in the two groups receiving vitamin A and beta-carotene compared to the placebo group (33, 26, and 59 deaths, respectively) which opened novel TWINNING RATES IN NEPAL 807 6 Potter EL. Twin zygosity and placental form in relation to the outcome and promising perspectives for prevention of maternal mortality and also created some controversy. 7, 8 In the present paper the authors focus on multiple birth as an outcome. They describe a relatively high rate of multiple births in this population of Nepal (12 per 1000 births in the control group), whereas mortality patterns among twins and triplets were similar to what could be expected from earlier studies. These data contribute important information to the epidemiology of multiple births. The most intriguing finding, however, is the differential occurrences of twin births seen across the intervention groups. Thus, twins occurred at a higher rate in the groups receiving retinol (99/5591) and beta-carotene (89/5148) than in the placebo group (65/5146). As in the Hungarian trial, it was not possible to say if the increased twin rate was due to generation of more twin conceptions or to greater survival among twin conceptions, and neither did the data permit a differentiation between effects on monozygotic versus dizygotic twin rates. Which substance(s) could be the causative factor(s)? The observational study focused on multivitamins in general, 5 whereas the common denominator of the two trials was retinoids. In the Nepal trial 23 300 IU of pre-formed vitamin A and 42 mg of all trans beta-carotene were given per week to the women in the two intervention groups, respectively. 7 In the Hungarian trial, 4000 or 6000 IU (in first and latter part of the trial, respectively) of pre-formed vitamin A was given per day (along with a number of other vitamins and minerals). [2] [3] [4] It may also be that it was an unspecific effect of dietary supplementation rather than an effect due to a particular component of the supplement.
Two other trials 9,10 are worth mentioning, which together with the Hungarian trial, 2 provide strong evidence regarding the preventive effect of peri-conceptional folate against neural tube effects. The MRC trial, published in 1991, recruited women who had had a baby with neural tube defects in an earlier pregnancy, and who wanted to get pregnant again. 9 Two placebocontrolled regimens were tested simultaneously in a factorial design, 4 mg folate per day, and a cocktail with (other) vitamins and minerals until week 12 of gestation; the cocktail included 4000 IU pre-formed vitamin A per day. Folate substantially reduced the recurrence risk of neural tube defects. Later, the authors showed a non-significant difference in the twin rate in the folate versus non-folate groups, 7/593 versus 5/600 (P = 0.76) (no data were presented regarding the vitamin/ mineral cocktail). 11 A meta analysis of the Hungarian and the MRC trial, plus another smaller randomized trial, exhibited an odds ratio of 1.40 (95% confidence interval 0.93-2.11) of twin pregnancies after peri-conceptional folate supplementation. 12 The recent China-US Collaborative Project for Neural Tube Defect Prevention, where more than 200 000 Chinese women participated in a non-randomized intervention with periconceptional folate, is likely to provide decisive evidence regarding the impact of 0.4 g folate on the twin rate. 10 Clarification of this matter is essential since, in many countries today, women who wish to get pregnant are advised to take this amount of folate to prevent neural tube defects.
In recent years large observational pregnancy cohorts have also been established in several countries. The Danish National Birth Cohort is by far the largest: it intends to recruit 100 000 pregnant women, and at the time of writing 65 000 women had been recruited. Peri-conceptional use of food supplements is recorded at recruitment, which typically takes place in week 6-10 of gestation. The data are likely to contribute important information regarding several of the issues discussed here.
